[ORGANIZATION]
GC Cell
Featured in 6 tracked stories · first seen
Situations
GC Cell advances GCC2005 CAR-NK therapy development
4 clusters · 6 sources · last updated
Latest: GC Cell begins Phase 1b clinical trials for GCC2005
GC Cell is advancing its GCC2005 CAR-NK cell therapy, a CD5-targeted allogeneic treatment for refractory T-cell lymphoma. The company has partnered with QuantHealth to use AI-based clinical trial simulations to optimize
Also covered in
-
GC Cell discusses immunotherapy commercialization in Türkiye
[BUSINESS] · 2 sources ·
-
GC Cell confirms Immuncell-LC improves survival in liver cancer transplant patients
[HEALTH] · 2 sources ·